PPARG and urinary bladder cancer: In a bladder cancer cell line (MB49), BCG induced PPARγ amplification, nuclear translocation and transcriptional activity, resulting in proliferation inhibition, which was strengthened by 15-d-PGJ2, a PPARγ agonist 34.